- Home
- HKIT vs ANEB Comparison
HKIT vs ANEB Comparison
Compare HKIT & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HKIT
- ANEB
- Stock Information
- Founded
- HKIT 1996
- ANEB 2020
- Country
- HKIT China
- ANEB United States
- Employees
- HKIT N/A
- ANEB N/A
- Industry
- HKIT Computer Software: Prepackaged Software
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- HKIT Technology
- ANEB Health Care
- Exchange
- HKIT Nasdaq
- ANEB Nasdaq
- Market Cap
- HKIT 35.7M
- ANEB 36.7M
- IPO Year
- HKIT 2023
- ANEB 2021
- Fundamental
- Price
- HKIT $1.25
- ANEB $1.14
- Analyst Decision
- HKIT
- ANEB Buy
- Analyst Count
- HKIT 0
- ANEB 1
- Target Price
- HKIT N/A
- ANEB $8.00
- AVG Volume (30 Days)
- HKIT 14.7K
- ANEB 19.7K
- Earning Date
- HKIT 05-06-2025
- ANEB 05-14-2025
- Dividend Yield
- HKIT N/A
- ANEB N/A
- EPS Growth
- HKIT N/A
- ANEB N/A
- EPS
- HKIT 0.04
- ANEB N/A
- Revenue
- HKIT $3,449,206.00
- ANEB N/A
- Revenue This Year
- HKIT N/A
- ANEB N/A
- Revenue Next Year
- HKIT N/A
- ANEB N/A
- P/E Ratio
- HKIT $33.40
- ANEB N/A
- Revenue Growth
- HKIT N/A
- ANEB N/A
- 52 Week Low
- HKIT $1.15
- ANEB $0.80
- 52 Week High
- HKIT $2.18
- ANEB $3.20
- Technical
- Relative Strength Index (RSI)
- HKIT 51.31
- ANEB 50.36
- Support Level
- HKIT $1.18
- ANEB $0.95
- Resistance Level
- HKIT $1.27
- ANEB $1.10
- Average True Range (ATR)
- HKIT 0.04
- ANEB 0.12
- MACD
- HKIT 0.01
- ANEB 0.02
- Stochastic Oscillator
- HKIT 77.87
- ANEB 92.31
About HKIT Hitek Global Inc.
Hitek Global Inc is a provider of information technology consulting and solutions services. The company has two lines of businesses such as services to small and medium businesses, which consist of Anti-Counterfeiting Tax Control System tax devices, including Golden Tax Disk and printers, ACTCS services, and IT services; and services to large businesses, which include hardware sales and software sales. It generates revenues from hardware sales, software sales, IT services, and tax devices and services.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.